JoVE
JoVE
Faculty Resource Center
Research
Behavior
Biochemistry
Biology
Bioengineering
Cancer Research
Chemistry
Developmental Biology
Engineering
Environment
Genetics
Immunology and Infection
Medicine
Neuroscience
JoVE Journal
JoVE Encyclopedia of Experiments
JoVE Chrome Extension
Education
Biology
Chemistry
Clinical
Engineering
Environmental Sciences
Pharmacology
Physics
Psychology
Statistics
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Business
Videos Mapped to your Course
Authors
Librarians
High Schools
About
Sign-In
Sign In
Contact Us
Research
JoVE Journal
JoVE Encyclopedia of Experiments
Education
JoVE Core
JoVE Science Education
JoVE Lab Manual
High Schools
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Close
Research
Behavior
Biochemistry
Bioengineering
Biology
Cancer Research
Chemistry
Developmental Biology
Engineering
Environment
Genetics
Immunology and Infection
Medicine
Neuroscience
Products
JoVE Journal
JoVE Encyclopedia of Experiments
Education
Biology
Chemistry
Clinical
Engineering
Environmental Sciences
Pharmacology
Physics
Psychology
Statistics
Products
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Business
Videos Mapped to Your Course
Teacher Resources
Get in Touch
Instant Trial
Log In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Journal
/
Medicine
/
抗がん剤の特異性を評価します<em>インビトロ</em
JoVE Journal
Medicine
This content is Free Access.
JoVE Journal
Medicine
Assessing Specificity of Anticancer Drugs
In Vitro
Please note that all translations are automatically generated.
Click here for the English version.
抗がん剤の特異性を評価します<em>インビトロ</em
DOI:
10.3791/53752-v
•
09:39 min
•
March 23, 2016
•
Lan Kluwe
2,3
1
Department of Maxillofacial Surgery
,
University Medical Center Hamburg-Eppendorf
,
2
Department of Neurology
,
University Medical Center Hamburg-Eppendorf
,
3
Laboratory for Tumor Biology and Regenerative Medicine
,
University Medical Center Hamburg-Eppendorf
Chapters
00:05
Title
01:00
Mix Culture of Both Tumor Cells and Non-tumor Cells and Drug Treatment
02:44
Preparing DNA for Digital PCR
04:51
Digital PCR
06:22
Calculating Tumor Cell Proportion
07:20
Results: Dose-Dependent Change of Tumor Cell Proportion and Responses of Tumor/Non-Tumor Cells
08:14
Conclusion
Summary
Automatic Translation
English (Original)
العربية (Arabic)
中文 (Chinese)
Nederlands (Dutch)
français (French)
Deutsch (German)
עברית (Hebrew)
italiano (Italian)
日本語 (Japanese)
한국어 (Korean)
português (Portuguese)
русский (Russian)
español (Spanish)
Türkçe (Turkish)
Automatic Translation
このプロトコルの目的は、腫瘍および非腫瘍細胞の両方を含む混合培養物を用いて
インビトロで
抗がん剤の特異性を評価することです。
Tags
In Vitro
Anticancer Drugs
Tumor Cells
Non-tumor Cells
Specificity
Drug Discovery
Personalized Cancer Care
Cell Culture
Nilotinib
Dose-dependent
HotSHOT Method
Cell Lysis
PCR
DNA
Article
Embed
ADD TO PLAYLIST
Usage Statistics
Related Videos
胎児性アルコール暴露のゼブラフィッシュモデルの催奇形性変化を評価する
骨肉腫細胞における光線力学療法の細胞毒性有効性<em>体外</em
と伝達性海綿状脳症種の障壁を評価する<em>インビトロ</em>プリオンタンパク質変換アッセイ
眼薬の薬物動態試験でウサギの眼の使用
薬物転用仮説生成の使用」RE:罰金薬「システム
フォルスコリン誘発性腸オルガノイドに腫れ:<em>インビトロ</em>アッセイ嚢胞性線維症患者における薬物反応を評価するための
新生児マウス蝸牛移植法<em>インビトロ</em>聴覚研究のスクリーニングツール
コレステロール粒子の形態を調節することで脂質低下薬の効果
ヒンドリム虚血のマウスモデルにおける治療血管新生の評価
冠動脈血管新生のインビトロモデル
Read Article